Review



human non small cell lung cancer nsclc cell lines a549  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC human non small cell lung cancer nsclc cell lines a549
    Human Non Small Cell Lung Cancer Nsclc Cell Lines A549, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 9070 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+non+small+cell+lung+cancer+nsclc+cell+lines+a549/pm41946943-73-0-15?v=ATCC
    Average 99 stars, based on 9070 article reviews
    human non small cell lung cancer nsclc cell lines a549 - by Bioz Stars, 2026-08
    99/100 stars

    Images



    Similar Products

    99
    ATCC human non small cell lung cancer nsclc cell lines a549
    Human Non Small Cell Lung Cancer Nsclc Cell Lines A549, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+non+small+cell+lung+cancer+nsclc+cell+lines+a549/pm41946943-73-0-15?v=ATCC
    Average 99 stars, based on 1 article reviews
    human non small cell lung cancer nsclc cell lines a549 - by Bioz Stars, 2026-08
    99/100 stars
      Buy from Supplier

    99
    ATCC culture conditions human non small cell lung cancer nsclc cell lines
    Culture Conditions Human Non Small Cell Lung Cancer Nsclc Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+non+small+cell+lung+cancer+nsclc+cell+lines+a549/pm40691840-82-3-23?v=ATCC
    Average 99 stars, based on 1 article reviews
    culture conditions human non small cell lung cancer nsclc cell lines - by Bioz Stars, 2026-08
    99/100 stars
      Buy from Supplier

    99
    ATCC human non small cell lung cancer nsclc cell line a549
    Rhein reduces CDDP-induced nephrotoxicity without affecting the antitumor efficacy. CDDP (10μg/mL)-treated human non-small-cell lung cancer <t>(NSCLC)</t> <t>A549</t> cells were incubated with 40 μM Rhein for 24 h. ( A ) The cell viability was determined by the CCK8 analysis (n=6). ( B ) The CDDP-sensitive Lewis lung carcinoma (LLC) cells (2×10 5 ) were inoculated subcutaneously into C57BL/6 mice for 14 days, and the mice were treated with CDDP alone (4 mg/kg, the drugs were administered every other day for 10 days, resulting in an accumulative dose of 20 mg/kg) or combination with Rhein (80mg/kg, the drugs were administered 1 hour after CDDP injection). ( C and D ) The xenograft tumor weights and tumor volume of C57BL/6 mice injected subcutaneously with LLC cells with the treatment of CDDP, Rhein alone or in combination with Rhein (n=5). Data are shown as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001: CDDP vs Control. ## P < 0.01 CDDP+Rhein vs CDDP.
    Human Non Small Cell Lung Cancer Nsclc Cell Line A549, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+non+small+cell+lung+cancer+nsclc+cell+lines+a549/pmc12136081-101-14-27?v=ATCC
    Average 99 stars, based on 1 article reviews
    human non small cell lung cancer nsclc cell line a549 - by Bioz Stars, 2026-08
    99/100 stars
      Buy from Supplier

    99
    ATCC a549 human non small cell lung cancer nsclc cell line
    Rhein reduces CDDP-induced nephrotoxicity without affecting the antitumor efficacy. CDDP (10μg/mL)-treated human non-small-cell lung cancer <t>(NSCLC)</t> <t>A549</t> cells were incubated with 40 μM Rhein for 24 h. ( A ) The cell viability was determined by the CCK8 analysis (n=6). ( B ) The CDDP-sensitive Lewis lung carcinoma (LLC) cells (2×10 5 ) were inoculated subcutaneously into C57BL/6 mice for 14 days, and the mice were treated with CDDP alone (4 mg/kg, the drugs were administered every other day for 10 days, resulting in an accumulative dose of 20 mg/kg) or combination with Rhein (80mg/kg, the drugs were administered 1 hour after CDDP injection). ( C and D ) The xenograft tumor weights and tumor volume of C57BL/6 mice injected subcutaneously with LLC cells with the treatment of CDDP, Rhein alone or in combination with Rhein (n=5). Data are shown as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001: CDDP vs Control. ## P < 0.01 CDDP+Rhein vs CDDP.
    A549 Human Non Small Cell Lung Cancer Nsclc Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+non+small+cell+lung+cancer+nsclc+cell+lines+a549/pm39220474__ao4c06568_si_001-8-2-16?v=ATCC
    Average 99 stars, based on 1 article reviews
    a549 human non small cell lung cancer nsclc cell line - by Bioz Stars, 2026-08
    99/100 stars
      Buy from Supplier

    90
    Procell Inc human non-small cell lung cancer (nsclc) cell line a549
    Rhein reduces CDDP-induced nephrotoxicity without affecting the antitumor efficacy. CDDP (10μg/mL)-treated human non-small-cell lung cancer <t>(NSCLC)</t> <t>A549</t> cells were incubated with 40 μM Rhein for 24 h. ( A ) The cell viability was determined by the CCK8 analysis (n=6). ( B ) The CDDP-sensitive Lewis lung carcinoma (LLC) cells (2×10 5 ) were inoculated subcutaneously into C57BL/6 mice for 14 days, and the mice were treated with CDDP alone (4 mg/kg, the drugs were administered every other day for 10 days, resulting in an accumulative dose of 20 mg/kg) or combination with Rhein (80mg/kg, the drugs were administered 1 hour after CDDP injection). ( C and D ) The xenograft tumor weights and tumor volume of C57BL/6 mice injected subcutaneously with LLC cells with the treatment of CDDP, Rhein alone or in combination with Rhein (n=5). Data are shown as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001: CDDP vs Control. ## P < 0.01 CDDP+Rhein vs CDDP.
    Human Non Small Cell Lung Cancer (Nsclc) Cell Line A549, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+non+small+cell+lung+cancer+nsclc+cell+lines+a549/pm38565333-57-2-32?v=Procell+Inc
    Average 90 stars, based on 1 article reviews
    human non-small cell lung cancer (nsclc) cell line a549 - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    99
    ATCC human non small cell lung cancer cell nsclc line a549
    Figure 4. Results of RNA-seq analysis of OA, HG and GA. The <t>A549</t> cell line was treated with OA, HG, a combination of OA and HG (COH) and GA, and the MOA of each compound was derived using transcriptome data. Gene set enrichment analysis (GSEA) was performed using the gene expression results derived from each compound. (A) Venn diagram is shown using the genes selected as DEGs as a result of RNA-seq analysis of OA, HG, COH and GA. Commonly selected DEGs in OA, HG and COH are highlighted in orange circles. (B) A volcano plot was constructed using gene expression information derived from COH. (C) GSEA results of OA, HG, COH and GA were calculated using the KEGG pathway gene sets and RNA-seq analysis results of OA, HG, COH and GA.
    Human Non Small Cell Lung Cancer Cell Nsclc Line A549, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+non+small+cell+lung+cancer+nsclc+cell+lines+a549/pm37798251-153-0-14?v=ATCC
    Average 99 stars, based on 1 article reviews
    human non small cell lung cancer cell nsclc line a549 - by Bioz Stars, 2026-08
    99/100 stars
      Buy from Supplier

    99
    ATCC human non small cell lung cancer nsclc cell lines
    Figure 4. Results of RNA-seq analysis of OA, HG and GA. The <t>A549</t> cell line was treated with OA, HG, a combination of OA and HG (COH) and GA, and the MOA of each compound was derived using transcriptome data. Gene set enrichment analysis (GSEA) was performed using the gene expression results derived from each compound. (A) Venn diagram is shown using the genes selected as DEGs as a result of RNA-seq analysis of OA, HG, COH and GA. Commonly selected DEGs in OA, HG and COH are highlighted in orange circles. (B) A volcano plot was constructed using gene expression information derived from COH. (C) GSEA results of OA, HG, COH and GA were calculated using the KEGG pathway gene sets and RNA-seq analysis results of OA, HG, COH and GA.
    Human Non Small Cell Lung Cancer Nsclc Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+non+small+cell+lung+cancer+nsclc+cell+lines+a549/pm37620447-255-0-35?v=ATCC
    Average 99 stars, based on 1 article reviews
    human non small cell lung cancer nsclc cell lines - by Bioz Stars, 2026-08
    99/100 stars
      Buy from Supplier

    Image Search Results


    Rhein reduces CDDP-induced nephrotoxicity without affecting the antitumor efficacy. CDDP (10μg/mL)-treated human non-small-cell lung cancer (NSCLC) A549 cells were incubated with 40 μM Rhein for 24 h. ( A ) The cell viability was determined by the CCK8 analysis (n=6). ( B ) The CDDP-sensitive Lewis lung carcinoma (LLC) cells (2×10 5 ) were inoculated subcutaneously into C57BL/6 mice for 14 days, and the mice were treated with CDDP alone (4 mg/kg, the drugs were administered every other day for 10 days, resulting in an accumulative dose of 20 mg/kg) or combination with Rhein (80mg/kg, the drugs were administered 1 hour after CDDP injection). ( C and D ) The xenograft tumor weights and tumor volume of C57BL/6 mice injected subcutaneously with LLC cells with the treatment of CDDP, Rhein alone or in combination with Rhein (n=5). Data are shown as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001: CDDP vs Control. ## P < 0.01 CDDP+Rhein vs CDDP.

    Journal: Drug Design, Development and Therapy

    Article Title: Rhein Alleviates Cisplatin-Induced Acute Kidney Injury via Downregulation of NOX4-COX2/PGFS Signaling Pathway

    doi: 10.2147/DDDT.S515409

    Figure Lengend Snippet: Rhein reduces CDDP-induced nephrotoxicity without affecting the antitumor efficacy. CDDP (10μg/mL)-treated human non-small-cell lung cancer (NSCLC) A549 cells were incubated with 40 μM Rhein for 24 h. ( A ) The cell viability was determined by the CCK8 analysis (n=6). ( B ) The CDDP-sensitive Lewis lung carcinoma (LLC) cells (2×10 5 ) were inoculated subcutaneously into C57BL/6 mice for 14 days, and the mice were treated with CDDP alone (4 mg/kg, the drugs were administered every other day for 10 days, resulting in an accumulative dose of 20 mg/kg) or combination with Rhein (80mg/kg, the drugs were administered 1 hour after CDDP injection). ( C and D ) The xenograft tumor weights and tumor volume of C57BL/6 mice injected subcutaneously with LLC cells with the treatment of CDDP, Rhein alone or in combination with Rhein (n=5). Data are shown as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001: CDDP vs Control. ## P < 0.01 CDDP+Rhein vs CDDP.

    Article Snippet: To determine whether Rhein might affect the anti-tumor activity of CDDP in vitro, CDDP-sensitive human non-small-cell lung cancer (NSCLC) cell line A549 (catalog no. CCL-185, RRID: CVCL_0023; ATCC, Manassas, VA, USA) was exposed to CDDP (10 μg/mL) alone or in combination with Rhein for 24h, cell viability was then measured.

    Techniques: Incubation, Injection, Control

    Figure 4. Results of RNA-seq analysis of OA, HG and GA. The A549 cell line was treated with OA, HG, a combination of OA and HG (COH) and GA, and the MOA of each compound was derived using transcriptome data. Gene set enrichment analysis (GSEA) was performed using the gene expression results derived from each compound. (A) Venn diagram is shown using the genes selected as DEGs as a result of RNA-seq analysis of OA, HG, COH and GA. Commonly selected DEGs in OA, HG and COH are highlighted in orange circles. (B) A volcano plot was constructed using gene expression information derived from COH. (C) GSEA results of OA, HG, COH and GA were calculated using the KEGG pathway gene sets and RNA-seq analysis results of OA, HG, COH and GA.

    Journal: Briefings in bioinformatics

    Article Title: Comparative study of the mechanism of natural compounds with similar structures using docking and transcriptome data for improving in silico herbal medicine experimentations.

    doi: 10.1093/bib/bbad344

    Figure Lengend Snippet: Figure 4. Results of RNA-seq analysis of OA, HG and GA. The A549 cell line was treated with OA, HG, a combination of OA and HG (COH) and GA, and the MOA of each compound was derived using transcriptome data. Gene set enrichment analysis (GSEA) was performed using the gene expression results derived from each compound. (A) Venn diagram is shown using the genes selected as DEGs as a result of RNA-seq analysis of OA, HG, COH and GA. Commonly selected DEGs in OA, HG and COH are highlighted in orange circles. (B) A volcano plot was constructed using gene expression information derived from COH. (C) GSEA results of OA, HG, COH and GA were calculated using the KEGG pathway gene sets and RNA-seq analysis results of OA, HG, COH and GA.

    Article Snippet: Human non-small cell lung cancer cell (NSCLC) line A549 (CCL185) was purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA).

    Techniques: RNA Sequencing, Derivative Assay, Gene Expression, Construct